tiprankstipranks
Trending News
More News >
Bristol-Myers Squibb (BMY)
NYSE:BMY
US Market
Advertisement

Bristol-Myers Squibb (BMY) Ratios

Compare
11,612 Followers

Bristol-Myers Squibb Ratios

BMY's free cash flow for Q1 2025 was $0.73. For the 2025 fiscal year, BMY's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.21 1.43 1.25 1.52 1.58
Quick Ratio
1.11 1.31 1.14 1.43 1.47
Cash Ratio
0.46 0.51 0.42 0.64 0.76
Solvency Ratio
0.15 0.27 0.25 0.24 0.02
Operating Cash Flow Ratio
0.58 0.62 0.60 0.74 0.74
Short-Term Operating Cash Flow Coverage
3.37 4.44 3.06 3.28 6.01
Net Current Asset Value
$ -43.97B$ -33.90B$ -38.43B$ -40.05B$ -50.41B
Leverage Ratios
Debt-to-Assets Ratio
0.54 0.44 0.42 0.42 0.44
Debt-to-Equity Ratio
2.92 1.41 1.31 1.27 1.37
Debt-to-Capital Ratio
0.74 0.58 0.57 0.56 0.58
Long-Term Debt-to-Capital Ratio
0.72 0.55 0.53 0.52 0.56
Financial Leverage Ratio
5.43 3.23 3.12 3.04 3.13
Debt Service Coverage Ratio
2.03 4.44 3.25 3.04 0.77
Interest Coverage Ratio
6.29 14.79 8.38 7.62 3.61
Debt to Market Cap
0.53 0.37 0.26 0.32 0.36
Interest Debt Per Share
26.00 20.60 19.69 21.13 23.51
Net Debt to EBITDA
2.54 1.55 1.64 1.57 7.37
Profitability Margins
Gross Profit Margin
61.74%76.24%78.04%78.57%72.31%
EBIT Margin
17.97%21.34%19.38%20.33%-12.82%
EBITDA Margin
31.63%43.14%41.66%43.53%11.84%
Operating Profit Margin
26.11%38.31%22.37%21.90%12.06%
Pretax Profit Margin
13.82%18.75%16.71%17.46%-16.16%
Net Profit Margin
10.58%17.83%13.71%15.08%-21.16%
Continuous Operations Profit Margin
10.62%17.86%13.75%15.12%-21.16%
Net Income Per EBT
76.56%95.08%82.03%86.37%130.91%
EBT Per EBIT
52.94%48.95%74.68%79.71%-133.99%
Return on Assets (ROA)
5.33%8.43%6.53%6.40%-7.59%
Return on Equity (ROE)
29.57%27.27%20.37%19.46%-23.78%
Return on Capital Employed (ROCE)
18.55%23.65%13.78%11.62%5.16%
Return on Invested Capital (ROIC)
13.28%21.56%10.71%9.51%6.59%
Return on Tangible Assets
9.85%17.10%16.09%15.19%-20.13%
Earnings Yield
5.40%7.56%4.13%5.05%-6.42%
Efficiency Ratios
Receivables Turnover
3.16 2.95 3.31 3.71 5.00
Payables Turnover
3.36 3.28 3.33 3.37 4.34
Inventory Turnover
6.67 4.02 4.33 4.74 5.68
Fixed Asset Turnover
5.52 5.60 6.18 6.66 6.30
Asset Turnover
0.50 0.47 0.48 0.42 0.36
Working Capital Turnover Ratio
7.69 6.04 5.50 4.12 3.84
Cash Conversion Cycle
61.75 103.41 84.97 67.13 53.17
Days of Sales Outstanding
115.54 123.79 110.21 98.49 72.98
Days of Inventory Outstanding
54.73 90.87 84.22 76.93 64.30
Days of Payables Outstanding
108.52 111.24 109.46 108.29 84.11
Operating Cycle
170.27 214.66 194.43 175.42 137.28
Cash Flow Ratios
Operating Cash Flow Per Share
7.81 6.70 6.13 7.30 6.22
Free Cash Flow Per Share
7.16 6.11 5.61 6.86 5.89
CapEx Per Share
0.65 0.58 0.52 0.44 0.33
Free Cash Flow to Operating Cash Flow
0.92 0.91 0.91 0.94 0.95
Dividend Paid and CapEx Coverage Ratio
2.53 2.33 2.27 3.02 2.91
Capital Expenditure Coverage Ratio
12.02 11.46 11.69 16.66 18.66
Operating Cash Flow Coverage Ratio
0.31 0.33 0.32 0.36 0.27
Operating Cash Flow to Sales Ratio
0.33 0.31 0.28 0.35 0.33
Free Cash Flow Yield
15.59%11.92%7.80%11.00%9.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.52 13.23 24.22 19.80 -15.57
Price-to-Sales (P/S) Ratio
1.96 2.36 3.32 2.99 3.29
Price-to-Book (P/B) Ratio
5.36 3.61 4.93 3.85 3.70
Price-to-Free Cash Flow (P/FCF) Ratio
6.42 8.39 12.83 9.09 10.53
Price-to-Operating Cash Flow Ratio
5.88 7.66 11.73 8.54 9.97
Price-to-Earnings Growth (PEG) Ratio
-2.61 0.43 -4.24 -0.11 0.05
Price-to-Fair Value
5.36 3.61 4.93 3.85 3.70
Enterprise Value Multiple
8.74 7.01 9.61 8.42 35.19
Enterprise Value
131.86B 136.16B 184.85B 170.10B 177.19B
EV to EBITDA
8.74 7.01 9.61 8.42 35.19
EV to Sales
2.76 3.03 4.00 3.67 4.17
EV to Free Cash Flow
9.05 10.76 15.47 11.17 13.32
EV to Operating Cash Flow
8.29 9.82 14.15 10.50 12.61
Tangible Book Value Per Share
-12.75 -9.07 -12.39 -12.28 -15.90
Shareholders’ Equity Per Share
8.57 14.22 14.58 16.18 16.75
Tax and Other Ratios
Effective Tax Rate
0.23 0.05 0.18 0.13 -0.31
Revenue Per Share
23.44 21.75 21.67 20.88 18.83
Net Income Per Share
2.48 3.88 2.97 3.15 -3.98
Tax Burden
0.77 0.95 0.82 0.86 1.31
Interest Burden
0.77 0.88 0.86 0.86 1.26
Research & Development to Revenue
0.20 0.21 0.21 0.22 0.26
SG&A to Revenue
<0.01 0.14 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.01 <0.01 0.01 0.02
Income Quality
3.14 1.72 2.06 2.31 -1.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis